Kolexia
Lambert Yves Médecine vasculaire
Lambert Yves
Médecine vasculaire
Cabinet libéral
Compiègne, France
21 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infarctus du myocarde avec sus-décalage du segment ST Infarctus du myocarde Infarctus Hémorragies intracrâniennes Choc cardiogénique Défaillance cardiaque Hémorragie {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Goldstein Patrick
Goldstein Patrick
Agence Regionale De Sante Hauts-de-france, Lille, France
Danays Thierry
Danays Thierry
Boehringer Ingelheim France, Paris, France
Bauge-Faraldi Odile
Bauge-Faraldi Odile
Centre Hospitalier Isarien, Clermont, France
Botoro Thierry
Botoro Thierry
Centre Hospitalier de Compiègne, Compiègne, France

Industries

Voir plus
Leo Pharma
1 collaboration(s)
Dernière en 2019
Aspen
1 collaboration(s)
Dernière en 2019
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
Circulation   13 juillet 2023
STREAM-2: STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
Essai Clinique (KU Leuven)   20 décembre 2022
Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" Am Heart J 169/6 (2015) 890-898.
American heart journal   20 novembre 2019
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction: STREAM (Strategic Reperfusion Early After Myocardial Infarction). Comparison of the Efficacy and Safety of a Strategy of Early Fibrinolytic Treatment With Tenecteplase and Additional Antiplatelet and Antithrombin Therapy Followed by Catheterisation Within 6-24 Hours or Rescue Coronary Intervention Versus a Strategy of Standard Primary PCI in Patients With Acute Myocardial Infarction Within 3 Hours of Onset of Symptoms
Essai Clinique (Boehringer Ingelheim)   06 juin 2019
Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial.
American heart journal   27 mars 2015
ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.
Circulation   26 août 2014
Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial.
Heart (British Cardiac Society)   10 juin 2014
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
The New England journal of medicine   10 mars 2013
Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology
Revista espanola de cardiologia (English ed.)   01 janvier 2012
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}